Phase 4
Completed N=79
Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS
Source: ClinicalTrials.gov NCT03644212 ↗Enrolled (actual)
79
Serious AEs
0.0%
Results posted
Jan 2020
Primary outcomePrimary: AMH Levels in Women With PCOS — 1.4; 0 ng/mL
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The purpose of this study is to investigate the mechanism that explain the beneficial clinical effect of vitamin D treatment in women with PCOS.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY AMH Levels in Women With PCOS |
1.4; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Vitamin D deficient premenopausal women
Exclusion Criteria
- Pregnant women
- Women during their postpartum period
- Breastfeeding women
- Women taking any kind of exogenous hormones
- Women receiving any form of oral vitamin D replacement
Data sourced from ClinicalTrials.gov (NCT03644212). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.